Literature DB >> 9157129

Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains.

S Nho1, M J Anderson, C B Moore, D W Denning.   

Abstract

PCR amplification of the regions containing the internally transcribed spacers and 5.8S rRNA gene of Candida krusei, C. inconspicua, and C. norvegensis yielded fragments of 510, 460, and 500 bp, respectively. HhaI digestion of these fragments yielded species-specific bands. Random amplification of polymorphic DNA with primer R108 showed interspecific discriminatory band patterns. Susceptibilities to fluconazole and amphotericin B were determined.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9157129      PMCID： PMC229734          DOI： 10.1128/jcm.35.4.1036-1039.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Mycoses in AIDS patients.

Authors:  B Dupont; D W Denning; D Marriott; A Sugar; M A Viviani; T Sirisanthana
Journal:  J Med Vet Mycol       Date:  1994

2.  Detection of amphotericin B-resistant Candida isolates in a broth-based system.

Authors:  J H Rex; C R Cooper; W G Merz; J N Galgiani; E J Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

Review 3.  Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.

Authors:  Y H Samaranayake; L P Samaranayake
Journal:  J Med Microbiol       Date:  1994-11       Impact factor: 2.472

4.  Fluconazole-resistant candidosis in an HIV cohort.

Authors:  G G Baily; F M Perry; D W Denning; B K Mandal
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

5.  Specific identification of Candida albicans by hybridization with oligonucleotides derived from ribosomal DNA internal spacers.

Authors:  A R Botelho; R J Planta
Journal:  Yeast       Date:  1994-06       Impact factor: 3.239

6.  Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.

Authors:  E M Johnson; D W Warnock; J Luker; S R Porter; C Scully
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

7.  Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua.

Authors:  S M Essayag; G G Baily; D W Denning; J P Burnie
Journal:  Int J Syst Bacteriol       Date:  1996-01

8.  Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus.

Authors:  A Aufauvre-Brown; J Cohen; D W Holden
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Rapid presumptive identification of medically relevant yeasts to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  M Maiwald; R Kappe; H G Sonntag
Journal:  J Med Vet Mycol       Date:  1994

10.  In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.

Authors:  H M Wardle; D Law; C B Moore; C Mason; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191
View more
  9 in total

Review 1.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Design and evaluation of peptide nucleic acid probes for specific identification of Candida albicans.

Authors:  Hyun-Joong Kim; Byron F Brehm-Stecher
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

3.  Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis.

Authors:  R Wahyuningsih; H J Freisleben; H G Sonntag; P Schnitzler
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Detection and identification of Candida species in experimentally infected tissue and human blood by rRNA-specific fluorescent in situ hybridization.

Authors:  A Lischewski; M Kretschmar; H Hof; R Amann; J Hacker; J Morschhäuser
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.

Authors:  Kevin C Hazen; Ellen Jo Baron; Arnaldo Lopes Colombo; Corrado Girmenia; Aurora Sanchez-Sousa; Amalia del Palacio; Catalina de Bedout; David L Gibbs
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

6.  Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.

Authors:  M J McCullough; K V Clemons; D A Stevens
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

7.  Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures.

Authors:  L Majoros; G Kardos; A Belák; A Maráz; L Asztalos; E Csánky; Z Barta; B Szabó
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Species diversity of yeast in oral colonization of insulin-treated diabetes mellitus patients.

Authors:  Regina Helena Pires Gonçalves; Elaine Toscano Miranda; José Eduardo Zaia; Maria José Soares Mendes Giannini
Journal:  Mycopathologia       Date:  2006-08       Impact factor: 3.785

Review 9.  Candida infections and their prevention.

Authors:  M Anaul Kabir; Zulfiqar Ahmad
Journal:  ISRN Prev Med       Date:  2012-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.